raynaud’s disease
Raynaud’s phenomenon is a condition that causes reduced blood supply to the fingers and toes in response to certain conditions such as, coldness, and cases of emotional stress. It causes pain, numbness and tingling in the areas affected and can be reversed through lifestyle and medical treatment.
Epidemiology
In most populations, Raynaud’s phenomenon is found to affect 3-5% of the general population
A 7-year study found that in white patients within the US, prevalence rates were 11% in women and 8% in men [1]
The prevalence ranges from 2-20% of women and 1-12% in men depending on factors such as geographic location and population studied [2]
In most cases, Raynaud’s phenomenon is in its primary stage (80-90%)
More common in women than men
Typically develops at a younger age (between the 20-30th years of life) [3]
Blue/white colour change of the extremities (toes) due to the constriction of blood vessels
Pathophysiology [4]
Medical students
Three mechanisms of Raynaud phenomenon:
Decreased blood flow
Blood vessel constriction
Neurogenic and inflammatory immune responses
Somatosensory system involved in temperature perception:
A-delta and unmyelinated C-fibers (nerve fibres related to pain) activated by cold temperatures
This triggers the activation of cold receptor TRPM8 for monitoring cold variations
TRPM8 activation leads to vasoconstriction, thermogenesis, and cold avoidance
Sympathetic nervous system response to cold temperatures:
Release of vasoconstricting neuropeptides and norepinephrine
Vasoconstriction of arteriole smooth muscle and reduced blood flow to the skin
Endothelin-1 release in secondary Raynaud phenomenon causing vasoconstriction
Primary Raynaud phenomenon:
Increase in alpha-2 adrenergic sensitivity in digital and cutaneous vessels
Vasoconstrictive response to cold temperatures and emotional stress
Alpha-2 adrenergic receptor inhibitors reduce severity of cold-induced attacks
Secondary Raynaud phenomenon:
Underlying disease disrupts vessel reactivity to cold temperatures
Endothelial function compromised leading to vasoconstriction and tissue ischemia
Patients
Three mechanisms of Raynaud phenomenon:
Decreased blood flow
Blood vessel narrowing
Neurogenic (involving nerves in the body) and inflammatory immune responses
Somatosensory (related to the body and senses) system involved in temperature perception:
Nerves responsible for the perception of pain are activated by cold temperatures
This causes the activation of cold receptors for monitoring cold variations
This leads to blood vessel narrowing, heat production which is lost to the surroundings, and cold avoidance
Sympathetic nervous system (this triggers your fight or flight) response to cold temperatures:
Release of hormones (chemicals in the body) which trigger blood vessel narrowing
Narrowing of the muscle layers of the artery and reduced blood flow to the skin
The protein, Endothelin-1, is released in secondary Raynaud syndrome (developed from a primary condition) causing blood vessel narrowing
Primary Raynaud phenomenon:
Increase in a nerve receptor sensitivity ( increased response to conditions in the body) found in the finger and skin blood vessels
Blood vessel narrowing is triggered in response to cold temperatures and emotional stress
Substances that stop the activation of certain nerve receptors leads to a reduction in the severity of cold-induced attacks
Secondary Raynaud phenomenon:
Underlying disease disrupts the body’s reaction to vessels in cold temperatures
Damage to the Endothelial function leads to blood vessel narrowing and reduction to oxygen supply to the tissue
Causes [5]
Primary- without being associated with another condition
Some evidence of inheritance (run in families)
Secondary- association with another condition
Autoimmune conditions (eg. rheumatoid arthritis, lupus) 1 in 10 patients are found to develop an autoimmune condition after being diagnosed with primary Raynaud’s syndrome
Infections such as Hepatitis B and C as well as blood born viral infections
Cancer (eg. ALL, myeloma)- can cause secondary Raynaud’s
Medicines including;
Anti-migraine medications
Beta-blockers
Chemotherapy
Contraceptive pills
And other drugs used to treat high blood pressure, hormone replacement, decongestants and illegal drugs like cocaine.
Injury and overuse
History of frostbite damaging skin and tissues
Vibration white finger (caused by vibrations from certain tools eg. hammer drills and chainsaws)
Risk factors [6]
Autoimmune diseases (eg. diabetes, arthritis, MS)
Chemical exposure
Smoking
Injury/ trauma to the skin
Overuse of actions such as using vibrating tools or typing
Certain medications (see above)
Presentation [7]
Coldness
Burning pain
Tingling (paraesthesia)
Discolouration of the fingers
Cyanosis (blueness)
Pallor (paleness)
Ulcer formation and tissue damage in sever cases of Raynaud’s syndrome
Investigations [5]
Clinical examination where hands are placed in cold water/air to check for the presentation of Raynaud’s syndrome in the clinic
Blood tests including;
A full blood count to check for infection
Antinuclear antibodies test (presence of proteins that protect your immune system) to check for an abnormally reactive immune system
Erythrocyte sedimentation rate (tests how quickly red blood cells can settle to the bottom of a test tube) to check for an immune system disorder (overreaction of the immune system)
Differential diagnosis [3]
Chilblains
Acrocyanosis- blueness triggered by the cold
Erythromelalgia- redness of the hands/feet
Obstructive vessel conditions (eg. embolism)
Livedo reticularis- blue discolouration of the skin and mottled skin (marked spots with patches of colour)
Peripheral (hands/feet) nerve injury
Shoulder-hand syndrome- causes continuous pain in the hands/feet associated with vessel reflex changes
Management [7]
Medical students
Lifestyle changes:
Avoidance of cold and smoking cessation
Use of relaxation techniques (e.g., biofeedback) or counselling if stress is a trigger
Medications:
Vasodilating calcium channel blockers (e.g., nifedipine, amlodipine, felodipine, isradipine)
Treatment of Secondary Raynaud Syndrome:
Focus on treating the underlying disorder
Similar medications to Primary Raynaud Syndrome:
Calcium channel blockers (e.g., nifedipine, amlodipine, felodipine, isradipine)
Additional treatments for ischemic ulcers may include antibiotics, analgesics, and surgical debridement
Low-dose aspirin may prevent thrombosis but could worsen vasospasm
Patients
Lifestyle changes:
Avoidance of cold and smoking cessation
Use of relaxation techniques (e.g., biofeedback) or counselling if stress is a trigger
Medications:
Vasodilating (blood vessel widening) drugs called calcium channel blockers (blocks the calcium intake to the heart) (e.g., nifedipine, amlodipine, felodipine, isradipine)
Treatment of Secondary Raynaud Syndrome:
Focus on treating the underlying disorder
Similar medications to Primary Raynaud Syndrome:
Calcium channel blockers (e.g., nifedipine, amlodipine, felodipine, isradipine)
Additional treatments for ischemic ulcers (sores caused by a lack of oxygen supply) may include antibiotics, analgesics, and surgical debridement (treating a wound in the skin)
Low-dose aspirin may prevent thrombosis (blood clot formation) but could worsen vasospasm (narrowing of the arteries caused by the constant narrowing movement of the arteries)
Complications [6]
Sore areas of the fingers may progress into tissue damage and death (gangrene)
Myths [8]
Raynaud’s is a rare disease
It only affects fingers and toes
Raynaud’s phenomenon is caused by poor circulation
The only treatment is to stay warm
Symptoms only include red, white and blue discolouration
Questions to ask your doctor
How can I avoid the reoccurrence of symptoms?
How is it diagnosed?
Is it a hereditary condition?
Will Raynaud’s get worse over time?
Support
Raynaud’s Association
NICE Guidelines
NHS Inform
Bibliography
[1] https://emedicine.medscape.com/articl/331197-overview#a4
[2] https://link.springer.com/chapter/10.1007/978-1-4939-1526-2_3
[3] https://cks.nice.org.uk/topics/raynauds-phenomenon/background-information/prevalence-incidence/
[6] https://www.hopkinsmedicine.org/health/conditions-and-diseases/raynauds-phenomenon
[8] https://www.raynauds.org/2017/10/16/infographic-ten-myths-about-raynauds-phenomenon/